CVS Health's Exit from Infusion Services - Impact on Healthcare and Patients
CVS Health Discontinues Coram Infusion Services
In a significant shift, CVS Health has announced that its Coram infusion services will be discontinued, which includes critical therapies for antibiotics, inotropic medications, and total parenteral nutrition. This abrupt change is poised to impact many patients who rely on these essential treatments, especially those benefiting from acute home infusion therapies.
Closure of Regional Pharmacies
As part of this strategy, CVS plans to close or sell 29 regional pharmacies. This decision not only affects the company's operations but also raises questions regarding the accessibility of vital healthcare services in local communities.
Impact on Patient Care
- Reduced access to antibiotics and inotropic medications
- Challenges for patients relying on total parenteral nutrition
- Disruption in the provision of acute home infusion therapies
These changes signal a shift in CVS Health’s approach to delivering medical services, highlighting a potential gap in patient care that could result from the closure of these pharmacies and the discontinuation of critical infusion services.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.